Biotechnology BMY Earnings: A snapshot of Bristol-Myers Squibb’s Q2 2023 results 3 years ago Biotechnology company Bristol Myers Squibb (NYSE: BMY) on Thursday said its second-quarter adjusted earnings decreased year-over-year, hurt by a fall… AbbVie (ABBV) Q2 2023 Earnings: Key financials and quarterly highlights 3 years ago AbbVie (NYSE: ABBV) reported second quarter 2023 earnings results today. Worldwide net revenues were $13.8 billion, down 4.9% on a… BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results 3 years ago Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the second quarter of… Infographic: Thermo Fisher Scientific (TMO) Q2 2023 Earnings Results 3 years ago Thermo Fisher Scientific Inc. (NYSE: TMO) reported second quarter 2023 earnings results today. Revenue declined 3% to $10.69 billion compared… Infographic: Highlights of UnitedHealth Group’s (UNH) Q2 2023 earnings 3 years ago Diversified healthcare company UnitedHealth Group (NYSE: UNH) reported higher earnings and revenues for the second quarter of 2023. The company… Ocean Biomedical focuses its malaria program to address chronic malaria crisis in sub-Saharan Africa 3 years ago Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it is focusing its multi-pronged malaria program to address the… Apogee Therapeutics set to go public. Here’s what you need to know 3 years ago The US IPO market has remained mostly sluggish so far this year, continuing the weakness experienced in 2022. Meanwhile, there… Ocean Biomedical (OCEA) joins the Russell 2000 Index 3 years ago Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has been included in the Russell 2000 Index and the broad-market… Ocean Biomedical granted US patent for bispecific cancer immunotherapy treatment 3 years ago Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Monday said its scientific co-founder Dr. Jack Elias has been granted a… Ocean Biomedical extends patent rights for idiopathic pulmonary fibrosis discovery to Europe 3 years ago Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Friday revealed that its scientific co-founder Dr. Jack Elias has received notice… Walgreens Boots Alliance (WBA) set to report Q3 results. What’s in the cards 3 years ago Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a leading retailer and wholesaler of health and wellness products, is scheduled to report… Avid Bioservices Inc. (CDMO) Q4 2023 Earnings Call Transcript 3 years ago Avid Bioservices Inc. (NASDAQ: CDMO) Q4 2023 earnings call dated Jun. 21, 2023 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President… Fundamental Research Corp. raises Ocean Biomedical’s price target to $17.63 per share 3 years ago Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday said that Fundamental Research Corp. increased the price target of the company’s stock… Earnings Summary: A snapshot of Catalent’s Q3 2023 results 3 years ago Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for… Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine 3 years ago Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said… Taglich Brothers initiates coverage of Ocean Biomedical, with price target of $20 3 years ago Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday revealed that Taglich Brothers initiated coverage on the company with a… Ocean Biomedical (OCEA) set to join the Russell 2000 Index 3 years ago Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said it is expected to be added to the Russell 2000 Index,… Ocean Biomedical (OCEA) announces patent award for novel cancer immunotherapy treatment 3 years ago Biopharma company Ocean Biomedical (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jack Elias has been issued a broad… Ocean Biomedical announces private placement of $25 mln convertible notes 3 years ago Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has entered into a private placement pursuant to a… Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7% 3 years ago Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported a decline in adjusted earnings for the first quarter of 2023, despite… Corcept Therapeutics Incorporated (CORT) Q1 2023 Earnings Call Transcript 3 years ago Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2023 Earnings Call dated May. 03, 2023 Corporate participants: Atabak Mokari -- Chief Financial… Next» « Previous